Herpes virus weaponized against brain cancer in new trial
Disease control
Not yet recruiting
This early-stage trial tests whether a modified herpes virus (C5252) injected into the brain is safe and can help people with recurrent malignant glioma, a type of aggressive brain tumor. About 36 adults whose tumors have returned after standard treatment will receive one or more…
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC